Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1955 4
1956 2
1957 2
1958 2
1959 6
1960 2
1961 3
1962 8
1963 16
1964 24
1965 21
1966 21
1967 17
1968 24
1969 25
1970 25
1971 29
1972 23
1973 79
1974 47
1975 70
1976 82
1977 50
1978 54
1979 52
1980 41
1981 75
1982 85
1983 80
1984 81
1985 99
1986 76
1987 72
1988 85
1989 102
1990 114
1991 132
1992 138
1993 152
1994 122
1995 269
1996 453
1997 502
1998 505
1999 527
2000 540
2001 489
2002 458
2003 512
2004 449
2005 481
2006 541
2007 539
2008 594
2009 558
2010 483
2011 509
2012 475
2013 533
2014 504
2015 507
2016 515
2017 573
2018 601
2019 626
2020 631
2021 548
2022 471
2023 356
2024 244

Search Results

15,583 results

Results by year

Filters applied: . Clear all
Page 1
Support, don't punish: Drug decriminalization is harm reduction.
Bratberg JP, Simmons A, Arya V, Bhatia A, Vakharia SP. Bratberg JP, et al. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):224-229. doi: 10.1016/j.japh.2022.12.017. Epub 2022 Dec 20. J Am Pharm Assoc (2003). 2023. PMID: 36682855
Buprenorphine and the Boards: Missed Opportunities.
Hayden M, Kishore S. Hayden M, et al. J Gen Intern Med. 2023 Jun;38(8):1984-1985. doi: 10.1007/s11606-023-08038-1. Epub 2023 Mar 29. J Gen Intern Med. 2023. PMID: 36988866 Free PMC article. No abstract available.
Access to naloxone in underserved communities.
Pérez-Figueroa RE, Oser CB, Malinowska K. Pérez-Figueroa RE, et al. BMJ. 2023 Apr 25;381:894. doi: 10.1136/bmj.p894. BMJ. 2023. PMID: 37185348 No abstract available.
Post-acute Withdrawal Syndrome.
Grover C, Sturgill D, Goldman L. Grover C, et al. J Addict Med. 2023 Mar-Apr 01;17(2):219-221. doi: 10.1097/ADM.0000000000001047. Epub 2022 Aug 8. J Addict Med. 2023. PMID: 36731102
Pruritus in Chronic Liver Disease.
Selim R, Ahn J. Selim R, et al. Clin Liver Dis. 2023 Feb;27(1):47-55. doi: 10.1016/j.cld.2022.08.011. Epub 2022 Oct 18. Clin Liver Dis. 2023. PMID: 36400466 Review.
Evidence on Buprenorphine Dose Limits: A Review.
Grande LA, Cundiff D, Greenwald MK, Murray M, Wright TE, Martin SA. Grande LA, et al. J Addict Med. 2023 Sep-Oct 01;17(5):509-516. doi: 10.1097/ADM.0000000000001189. Epub 2023 Jun 16. J Addict Med. 2023. PMID: 37788601 Free PMC article. Review.
Extended-release monthly buprenorphine injection.
Cuperfain AB, Costa T, Chopra N. Cuperfain AB, et al. CMAJ. 2023 Jan 9;195(1):E14. doi: 10.1503/cmaj.220730. CMAJ. 2023. PMID: 36623857 Free PMC article. No abstract available.
15,583 results
You have reached the last available page of results. Please see the User Guide for more information.